The World Anti-Doping Agency (WADA) Executive Committee held its second meeting this year in Sydney, Australia, where it made several important decisions and made recommendations for the future for the next meeting in November.
“I was very pleased with the level of discussion and cooperation among the members of the Executive Committee,” said agency president Wittold Banka after the meeting.
He explained, “After taking into account the recommendations of the experts, we took several important decisions, most notably the approval of the 2023 Prohibition List, which will become effective as of January 1, 2023.”
The list of new prohibited items included the drug “tramadol”, which will be postponed until January 1, 2024.
The agency justified this decision by giving sufficient opportunity for an additional year to equip athletes, their surroundings and special medical devices, to ensure a better understanding of this ban.
This period also gives space for the scientific community to amend some details of the fairness of sports competition, and also leaves the sports authorities the opportunity to work on the safe use of this drug for medical purposes only.
The drug “tramadol” was on the agency’s radar, and research showed its large use in sports, and the extent of the harms of its misuse.
In its statement, the agency stressed the continued ban on “hemp”, the plant from which “hashish” is extracted, a matter that began to be reviewed in September 2021, as it is prohibited during competitions only.
After consulting experts in various scientific and sports fields in 9 countries around the world, the agency reached results confirming that it can improve sports performance, poses a threat to the health of athletes, and its use is considered a violation of the spirit of sports, and accordingly the ban continued to be imposed.